CALLIE ROTHWELL: Open Payments
NPI 1629441282 · METAIRIE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,861 in 77 payments from 16 companies in 2025. Trend: 2023 $1,268 · 2024 $1,221 · 2025 $1,861
Food & beverage: $1,861
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $489 |
| Regeneron Healthcare Solutions, Inc. | 12 | $237 |
| GlaxoSmithKline, LLC. | 14 | $221 |
| GENZYME CORPORATION | 8 | $147 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $114 |
| Ionis Pharmaceuticals, Inc. | 4 | $99 |
| CSL Behring | 4 | $86 |
| Grifols USA, LLC | 4 | $82 |
| ABBVIE INC. | 4 | $78 |
| Novartis Pharmaceuticals Corporation | 4 | $77 |
Products named: DUPIXENT, FASENRA, TEZSPIRE, TRELEGY ELLIPTA, NEFFY, NUCALA, Xembify, DAWNZERA.
Industry payments across LA — which companies pay providers there.
